| Literature DB >> 35455884 |
Silvia Beatríz García-González1,2, María Raquel Huerta-Franco1, Israel Miguel-Andrés3, José de Jesús Mayagoitia-Vázquez3, Miguel León-Rodríguez4, Karla Barrera-Beltrán2, Gilberto Espinoza-Macías5.
Abstract
After mastectomy, women might lose mobility and develop kinematic changes in the shoulder. The objective of this research was to compare the kinematics of the glenohumeral joint in women, before and after unilateral breast cancer surgery. This was a longitudinal study with a pre- and post-evaluation design; in total, 15 Mexican women who had a mastectomy for breast cancer and who received a physical therapy program after surgery were evaluated. Flexion-extension and abduction-adduction movements of the glenohumeral joint were evaluated (15 days before and 60 days after mastectomy). For the kinematic analysis of the glenohumeral joint, an optoelectronic motion capture system was used to monitor 41 reflective markers located in anatomical landmarks. There was no significant difference in the range of motion of the glenohumeral joint when comparing pre- and post-mastectomy, flexion-extension (p = 0.138), and abduction-adduction (p = 0.058). Furthermore, patients who received chemotherapy (53%) before mastectomy were more affected (lower range of motion) than those who did not receive it. There were no significant differences in the kinematics of the glenohumeral joint after mastectomy in this group of patients who received a physical therapy program after surgery. Moreover, patients who received chemotherapy treatment before breast cancer surgery tended to have a lower range of motion than those who did not receive it. Therefore, it is necessary for the physical rehabilitation team to attend to these patients even before the mastectomy.Entities:
Keywords: breast cancer; glenohumeral joint; kinematics; mastectomy
Year: 2022 PMID: 35455884 PMCID: PMC9030468 DOI: 10.3390/healthcare10040707
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Anthropometric characteristics of the participants and data related to breast cancer.
| Anthropometric Data | Measurement | Clinical Data | Measurement |
|---|---|---|---|
| Age (years) | 46.7 ± 8.2 | Stage cancer I and II | 8 (53.3%) |
| Body weight (kg) | 68.4 ± 7.2 | Stage cancer III | 7 (46.7%) |
| Height (cm) | 156.9 ± 5.1 | Chemotherapy (yes) | 8 (53.3%) |
| Body mass index | 27.8 ± 3.1 | Axillary lymph node dissection (yes) | 11 (73.3%) |
std = standard deviation of the mean; n = the number of participants.
Figure 1Placement of the markers in specific bony landmarks: (a) anterior view and (b) posterior view. R and L, the right and left sides of the evaluated volunteer.
Figure 2Three orthogonal coordinate systems were created to measure the kinematics of the glenohumeral joint of the affected side: (a) isometric view of the reconstructed markers of the participant; (b) abduction movement of the left arm. CS, coordinate system; L AC joint, left acromioclavicular joint; C7, 7th cervical vertebra.
Figure 3Mean and standard deviation of the range of motion of the glenohumeral joint, before and after breast cancer surgery: (a) flexion–extension before mastectomy; (b) flexion–extension after mastectomy. Movement of the axis of the arm with respect to the axis of the torso, from .
Figure 4Mean and standard deviation of the range of motion of the glenohumeral joint, before and after breast cancer surgery: (a) abduction–adduction before mastectomy; (b) abduction–adduction after mastectomy. Movement of the axis of the arm with respect to the axis of the torso, from .
Comparison of the range of motion of the glenohumeral joint, between patients who received chemotherapy and those who did not receive this treatment before mastectomy.
| Range of Motion | Patients with Chemotherapy Treatment | Patients without Chemotherapy Treatment | |
|---|---|---|---|
| Flexion–extension | 92.0 ± 8.5 | 113.5 ± 11.3 | 0.001 * |
| Abduction–adduction Median (Q1–Q3) | 101.2 (70.7–103.7) | 114.8 (103.3–126.7) | 0.015 ** |
Q1 and Q3, quartiles 1 and 3; std, standard deviation of the mean. * Significance was obtained with Student’s t-test for independent samples. ** Significance was obtained with the Mann–Whitney U test for independent samples.
Comparison of the range of motion of the glenohumeral joint before and after mastectomy. Group 1, women who did not receive chemotherapy before mastectomy; Group 2, women who received chemotherapy before mastectomy.
| Group | Movement | Before | After | |
|---|---|---|---|---|
| 1 | Flexion–extension | 113.5 ± 11.3 | 107.3 ± 15.4 | 0.384 * |
| 2 | Flexion–extension | 92.0 ± 8.5 | 84.7 ± 11.3 | 0.243 * |
| 1 | Abduction–adduction | 114.8 (103.3–126.7) | 108.4 (94.3–117.4) | 0.233 ** |
| 2 | Abduction–adduction | 101.2 (77.8–103.7) | 87.6 (68.3–99.8) | 0.176 ** |
Q1 and Q3, quartiles 1 and 3; std, standard deviation of the mean. * Significance was obtained with Student’s t-test for dependent samples. ** Significance was obtained with the Wilcoxon rank-sum test.